Working with a MIPS support partner

A MIPS support partner is a consulting and operational support resource for the practice. For 2026, the partner should help the practice understand what needs to be reviewed, what data must be organized, what documentation should be tracked, and which internal workflows need attention before the reporting year advances too far.

• Support 2026 eligibility review using official QPP resources
• Help review clinician, group, and TIN/NPI participation considerations
• Support low-volume threshold review using allowed charges, Medicare Part B patient count, and covered services
• Help compare Traditional MIPS, MVP, APP, and other applicable reporting pathways
• Organize quality measure planning around specialty, patient population, denominator logic, and documentation workflows
• Track quality performance and 75% data completeness readiness
• Help organize Improvement Activities documentation for the required performance period
• Support Promoting Interoperability readiness review with EHR workflow considerations
• Help the practice understand Cost category exposure, even though Cost is generally claims-calculated
• Organize submission preparation through the practice's selected reporting pathway

The value of a support partner is not just technical knowledge. The value is operational discipline: knowing what to review early, what to monitor during the year, what to document, and what to verify before submission preparation begins.

One of the first responsibilities of a MIPS support partner is to help the practice review 2026 eligibility before measure planning begins. Eligibility should not be assumed based only on specialty, prior-year participation, or provider count.

For 2026, practices should review whether each applicable clinician or group is required to participate, opt-in eligible, voluntarily reporting, excluded, or participating through an Advanced APM pathway. Eligibility should be reviewed by clinician, group, and TIN/NPI combination where applicable.

• Confirm whether each clinician is a 2026 MIPS eligible clinician type
• Confirm Medicare enrollment timing
• Review each applicable TIN/NPI combination
• Confirm whether the clinician or group exceeds the 2026 low-volume threshold
• Review the 2026 low-volume threshold: more than $90,000 in Medicare Part B covered professional services, more than 200 Medicare Part B patients, and more than 200 covered professional services
• Review whether the practice is required to participate, opt-in eligible, voluntarily reporting, excluded, or participating through an Advanced APM pathway
• Recheck official QPP eligibility status before submission planning is finalized

A support partner can help organize the eligibility review process, but official eligibility status is governed by CMS/QPP rules and should be verified through official QPP resources.

For 2026, pathway selection affects measure requirements, reporting level, registration needs, data collection, documentation, and submission preparation. A support partner should help the practice compare available pathways before the year is too far underway.

• Review whether Traditional MIPS, MVP, APP, or another applicable pathway should be considered
• Confirm whether reporting will be individual, group, subgroup, virtual group, or APM Entity
• Compare Traditional MIPS quality requirements against MVP quality requirements
• Confirm whether the practice needs 6 Traditional MIPS quality measures or 4 MVP quality measures
• Review whether an available MVP fits the practice's specialty, patient population, and documentation workflows
• If reporting an MVP, confirm the April 1 to November 30, 2026 MVP registration window
• Review subgroup considerations for multispecialty groups where applicable
• Confirm the submission method and responsible party early

A good support partner should not push a pathway just because it sounds simpler. The correct path depends on eligibility, specialty fit, measure availability, data capture, documentation workflows, EHR capability, reporting level, and operational feasibility.

Measure selection is one of the most important parts of 2026 MIPS readiness. A support partner should help the practice select measures that are clinically relevant, operationally realistic, and supported by available documentation.

For 2026 Traditional MIPS, practices generally report 6 quality measures, including 1 outcome measure or high-priority measure, or a complete specialty set when applicable. For 2026 MVP reporting, participants generally report 4 quality measures from the selected MVP, including 1 outcome measure or high-priority measure when applicable. Quality data is generally collected for the full 12-month performance period from January 1 through December 31, 2026. Each reported quality measure must generally meet 75% data completeness.

• Review measure fit by specialty and patient population
• Confirm denominator volume and case minimum considerations
• Review numerator actions, denominator exclusions, and denominator exceptions
• Confirm whether each measure has a benchmark and can be reliably scored
• Confirm whether the EHR can capture the measure data correctly
• Track both performance rate and data completeness
• Confirm each selected measure can meet 75% data completeness
• Review documentation gaps before they become year-end submission issues

A support partner should not only ask what the performance rate is. The partner should also review denominator capture, numerator documentation, exclusions, exceptions, case minimum, benchmark availability, and data completeness.

A 2026 MIPS support partner should help the practice select and document the required number of Improvement Activities based on the reporting pathway, practice size, and applicable QPP status.

Beginning with the 2025 performance period, individual Improvement Activities are no longer assigned high or medium weights. For 2026 Traditional MIPS, practices generally attest to 2 Improvement Activities. Small practices and certain clinicians generally need 1 Improvement Activity. For MVP reporting, participants generally attest to 1 Improvement Activity from the selected MVP or attest to Patient-Centered Medical Home status when applicable.

• Confirm the required number of Improvement Activities for the practice's reporting pathway
• Confirm whether small practice or special status considerations apply
• Select activities that reflect work the practice can actually perform and document
• Document the activity for the required continuous 90-day period unless the activity description states otherwise
• October 3, 2026 is the last day to begin a continuous 90-day period that runs through December 31, 2026
• Keep documentation showing what was performed, when it was performed, who was responsible, and how the activity was maintained

Promoting Interoperability is often one of the most operationally sensitive MIPS categories because it depends on CEHRT, EHR configuration, workflow setup, measure reports, exclusions, attestations, patient access, health information exchange, electronic prescribing, public health reporting, and security risk analysis documentation.

For 2026, PI generally requires at least 180 continuous days of CEHRT data during the calendar year unless the category is reweighted or an applicable exception applies.

• Confirm whether Promoting Interoperability applies or may be reweighted
• Verify CEHRT status with the EHR team
• Confirm the PI performance period before it begins
• July 5, 2026 is the last day to start a 180-day PI performance period that runs through December 31, 2026
• Review required PI measures and attestations
• Review exclusions, hardship considerations, and special status considerations where applicable
• Confirm security risk analysis documentation is organized
• Validate EHR-generated PI reports before submission preparation

A support partner can help coordinate PI readiness, but the practice and EHR team should verify CEHRT configuration, measure logic, and official reporting requirements.

A MIPS support partner can help organize data, documentation, measure mapping, gap review, and submission readiness. However, submission preparation support is not the same as acting as a Qualified Registry, QCDR, official QPP entity, or government-affiliated submission mechanism.

• Confirm the selected reporting pathway and reporting level
• Confirm whether the practice will submit as an individual, group, subgroup, virtual group, or APM Entity
• Confirm the selected submission method and responsible party
• Review quality measure completeness before submission
• Organize Improvement Activities documentation
• Review PI reports, exclusions, attestations, CEHRT status, and security risk analysis documentation
• Confirm whether Cost is expected to be scored or reweighted
• Keep copies of submitted data, confirmation records, and supporting documentation
• Prepare materials through the practice's selected reporting pathway

A support partner should be clear about its boundaries. MIPS eligibility, scoring, category weights, reporting requirements, reweighting, payment adjustments, and final outcomes are governed by CMS/QPP rules. A support partner can help the practice prepare, organize, and review information, but it cannot control official determinations.

• Cannot guarantee MIPS eligibility status
• Cannot guarantee a final score
• Cannot guarantee a positive payment adjustment
• Cannot guarantee that a negative payment adjustment will not apply
• Cannot override official QPP eligibility determinations
• Cannot change CMS/QPP scoring rules
• Cannot control whether Cost measures are attributed or scored
• Cannot act as a Qualified Registry unless it is officially qualified for that role
• Cannot imply government affiliation
• Cannot replace the practice's responsibility to verify official QPP guidance

A trustworthy support partner should avoid guarantee language and should encourage the practice to verify current rules through official QPP resources.

Before engaging a MIPS support partner for 2026, practices should evaluate whether the partner understands both the rules and the operational realities of reporting. The partner should be able to explain the process clearly, identify documentation risks, respect compliance boundaries, and work with the practice's existing systems.

• Does the partner understand 2026 eligibility and low-volume threshold criteria?
• Does the partner review TIN/NPI combinations and reporting level?
• Does the partner understand Traditional MIPS, MVP, APP, and applicable pathway differences?
• Does the partner track data completeness, not just performance rate?
• Does the partner understand the 2026 requirement for 75% quality data completeness?
• Does the partner avoid outdated Improvement Activities high/medium weight language?
• Does the partner understand the 180-day PI requirement and CEHRT dependency?
• Does the partner help organize documentation before year-end?
• Does the partner clearly explain what it can and cannot do?
• Does the partner avoid CMS-approved, Qualified Registry, guaranteed score, and official affiliation language unless legally true?